Skip to main content

Table 1 Studies used for the second and third levels of our meta-analysis: genes expressed differently in the transition from normal prostate and localized prostate cancer to metastatic disease (Oncomine datasets)

From: Prioritizing genes associated with prostate cancer development

Primary author's name PMID Tissue type (no. of samples) Class 1 Class 2 Total no. of genes Level
Dhanasekaran 11518967 Normal prostate (22)
Primary prostate cancer (59)
9,956 2
Dhanasekaran_2 15548588 Normal adjacent prostate (12)
Prostate cancer (25)
19,650 2
Holzbeierlein 14695335 Normal prostate (4)
Prostate cancer (23)
5,854 2
Lapointe 14711987 Normal prostate (41)
Prostate carcinoma (62)
19,116 2
Luo 11406537 Benign hyperplasia (9)
Prostate carcinoma (16)
6,500 2
Nanni 16513839 Normal prostate (3)
Prostate carcinoma (22)
22,283 2
Tomlins 17173048 Benign prostate (22)
Prostate carcinoma (30)
19,355 2
Vanaja 12873976 Normal prostate (8)
Prostate adenocarcinoma (27)
44,928 2
Varambally 16286247 Benign prostate (6)
Prostate carcinoma (7)
54,675 2
Welsh 11507037 Normal prostate (9)
Prostate carcinoma (25)
11,138 2
Yu 15254046 Normal prostate (23)
Prostate carcinoma (64)
12,625 2
Dhanasekaran 11518967 Primary prostate cancer (59)
Metastatic prostate cancer (20)
9,935 3
Dhanasekaran_2 15548588 Prostate cancer (25)
Metastatic prostate cancer (6)
18,502 3
Tomlins 17173048 Prostate carcinoma (30)
Metastatic prostate cancer (19)
19,337 3
Yu 15254046 Prostate carcinoma (64)
Metastatic prostate cancer (25)
12,625 3
Vanaja 12873976 Prostate adenocarcinoma (27)
Metastatic prostate cancer (5)
44,928 3
Holzbeierlein 14695335 Prostate cancer (23)
Metastatic prostate cancer (9)
6,475 3
LaTulippe 12154061 Prostate carcinoma (23)
Metastatic prostate cancer (9)
12,600 3